These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 16603528)

  • 1. In vivo antiviral activity: defective interfering virus protects better against virulent Influenza A virus than avirulent virus.
    Dimmock NJ; Marriott AC
    J Gen Virol; 2006 May; 87(Pt 5):1259-1265. PubMed ID: 16603528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterologous protection of mice from a lethal human H1N1 influenza A virus infection by H3N8 equine defective interfering virus: comparison of defective RNA sequences isolated from the DI inoculum and mouse lung.
    Duhaut SD; Dimmock NJ
    Virology; 1998 Sep; 248(2):241-53. PubMed ID: 9721233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influenza virus protecting RNA: an effective prophylactic and therapeutic antiviral.
    Dimmock NJ; Rainsford EW; Scott PD; Marriott AC
    J Virol; 2008 Sep; 82(17):8570-8. PubMed ID: 18579602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Defective Interfering Influenza RNA Inhibits Infectious Influenza Virus Replication in Human Respiratory Tract Cells: A Potential New Human Antiviral.
    Smith CM; Scott PD; O'Callaghan C; Easton AJ; Dimmock NJ
    Viruses; 2016 Aug; 8(8):. PubMed ID: 27556481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defective interfering type A equine influenza virus (H3N8) protects mice from morbidity and mortality caused by homologous and heterologous subtypes of influenza A virus.
    Noble S; Dimmock NJ
    J Gen Virol; 1994 Dec; 75 ( Pt 12)():3485-91. PubMed ID: 7996140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of putative defective interfering (DI) A/WSN RNAs isolated from the lungs of mice protected from an otherwise lethal respiratory infection with influenza virus A/WSN (H1N1): a subset of the inoculum DI RNAs.
    Noble S; Dimmock NJ
    Virology; 1995 Jun; 210(1):9-19. PubMed ID: 7793084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homologous interference mediated by defective interfering influenza virus derived from a temperature-sensitive mutant of influenza virus.
    Nayak DP; Tobita K; Janda JM; Davis AR; De BK
    J Virol; 1978 Oct; 28(1):375-86. PubMed ID: 702654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of three strains of mice against lethal influenza in vivo by defective interfering virus.
    Morgan DJ; McLain L; Dimmock NJ
    Virus Res; 1993 Aug; 29(2):179-83. PubMed ID: 8212859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The genomic sequence of defective interfering Semliki Forest virus (SFV) determines its ability to be replicated in mouse brain and to protect against a lethal SFV infection in vivo.
    Thomson M; White CL; Dimmock NJ
    Virology; 1998 Feb; 241(2):215-23. PubMed ID: 9499796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection of mice from lethal influenza: evidence that defective interfering virus modulates the immune response and not virus multiplication.
    Dimmock NJ; Beck S; McLain L
    J Gen Virol; 1986 May; 67 ( Pt 5)():839-50. PubMed ID: 2422317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One defective interfering particle per cell prevents influenza virus-mediated cytopathology: an efficient assay system.
    McLain L; Armstrong SJ; Dimmock NJ
    J Gen Virol; 1988 Jun; 69 ( Pt 6)():1415-9. PubMed ID: 3385408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of a purely clonal defective interfering influenza virus.
    Yamagata Y; Muramoto Y; Miyamoto S; Shindo K; Nakano M; Noda T
    Microbiol Immunol; 2019 May; 63(5):164-171. PubMed ID: 30997933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of extracellular West Nile virus particles produced by cell cultures from genetically resistant and susceptible mice indicates enhanced amplification of defective interfering particles by resistant cultures.
    Brinton MA
    J Virol; 1983 Jun; 46(3):860-70. PubMed ID: 6304346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of virulent and avirulent A/chicken/Pennsylvania/83 influenza A viruses: potential role of defective interfering RNAs in nature.
    Bean WJ; Kawaoka Y; Wood JM; Pearson JE; Webster RG
    J Virol; 1985 Apr; 54(1):151-60. PubMed ID: 3973976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective influenza A virus generated entirely from plasmids: its RNA is expressed in infected mouse lung and modulates disease.
    Duhaut SD; Dimmock NJ
    J Virol Methods; 2003 Mar; 108(1):75-82. PubMed ID: 12565156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection of mice infected with a lethal dose of Semliki Forest virus by defective interfering virus: modulation of virus multiplication.
    Barrett AD; Guest AR; Mackenzie A; Dimmock NJ
    J Gen Virol; 1984 Nov; 65 ( Pt 11)():1909-20. PubMed ID: 6094709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defective interfering virus particles modulate virulence.
    Cave DR; Hendrickson FM; Huang AS
    J Virol; 1985 Aug; 55(2):366-73. PubMed ID: 2991562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defective interfering influenza virus RNAs: time to reevaluate their clinical potential as broad-spectrum antivirals?
    Dimmock NJ; Easton AJ
    J Virol; 2014 May; 88(10):5217-27. PubMed ID: 24574404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective interfering virus protects elderly mice from influenza.
    Scott PD; Meng B; Marriott AC; Easton AJ; Dimmock NJ
    Virol J; 2011 May; 8():212. PubMed ID: 21549019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Live Attenuated Influenza Vaccine contains Substantial and Unexpected Amounts of Defective Viral Genomic RNA.
    Gould PS; Easton AJ; Dimmock NJ
    Viruses; 2017 Sep; 9(10):. PubMed ID: 28934167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.